TABLE 2.
Spearman correlations between serologies and cytokines profile in the COVID‐19 cases of the case‐control cohort
| Anti‐S1 IgG r; P‐value |
Anti‐N total ab r; P‐value |
Anti‐apoA‐1 IgG r; P‐value |
Anti‐pneumococcal IgG r; P‐value |
|
|---|---|---|---|---|
| Serologies | ||||
| Anti‐S1 IgG; ratio | ND | 0.70;<.0001 | 0.60;<.0001 | −0.07; .50 |
| Anti‐N total ab; ratio | 0.70; <0.0001 | ND | 0.54;<.0001 | 0.07; .47 |
| Anti‐apoA‐1 IgG, OD450 | 0.60; <0.0001 | 0.54;<.0001 | ND | −0.03; .77 |
| Anti‐pneumococcal (Pn14) IgG, pg/mL | −0.07; 0.50 | 0.07; .47 | −0.03; .77 | ND |
| Cytokines | ||||
| IFN‐γ, pg/mL | 0.15; 0.14 | 0.12; .25 | −0.05; .63 | 0.01; .91 |
| IL‐6, pg/mL | 0.41; <0.0001 | 0.45; <.0001 | 0.36;<.0001 | −0.05; .59 |
| TNF‐α, pg/mL | 0.38; 0.0001 | 0.40; <.0001 | 0.26; .001 | −0.07; .47 |
| MCP‐1, pg/mL | 0.30; 0.003 | 0.14; .18 | −0.05; .73 | 0.09; .36 |
| IFN‐α2a, pg/mL | 0.43; <0.0001 | 0.37; .0001 | 0.26; .007 | −0.05; .62 |
Abbreviations: Anti‐N total ab, anti‐N antigen total antibodies; ND, not determined.